M&T Bank
GPCR icon

M&T Bank’s Structure Therapeutics GPCR Stock Holding History

M&T Bank’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,110
Closed -$492K – 1604
2024
Q4 		$492K Buy
18,110
+9,055
+100% +$321K ﹤0.01% 1174
2024
Q3 		$397K Sell
9,055
-9,063
-50% -$350K ﹤0.01% 1245
2024
Q2 		$712K Buy
18,118
+1,998
+12% +$82K ﹤0.01% 980
2024
Q1 		$690K Buy
16,120
+1,520
+10% +$64.1K ﹤0.01% 1014
2023
Q4 		$596K Buy
+14,600
New +$837K ﹤0.01% 1063

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

M&T Bank's GPCR Position: Q1 2025 in Review

M&T Bank sold out of Structure Therapeutics (GPCR) in Q1 2025, closing a stake of 18,110 shares — an estimated $492K sold.

M&T Bank first reported a position in GPCR in Q4 2023 and held it in 5 quarters. The position peaked at $712K in Q2 2024. 150 funds tracked by Wall St. Rank hold GPCR as of Q1 2025.

  • M&T Bank reported no remaining Structure Therapeutics position as of Q1 2025 after selling out during the quarter.
  • M&T Bank sold 18,110 Structure Therapeutics shares in Q1 2025, an estimated $492K.
  • M&T Bank first reported a position in Structure Therapeutics in Q4 2023 and held it in 5 quarters.
  • M&T Bank's Structure Therapeutics position peaked at $712K in Q2 2024.
  • 150 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2025.

Based on M&T Bank's 13F filing for Q1 2025, filed 30 Apr 2025.